- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 12770 High Bluff Drive, Suite 380 San Diego CA United States of America 92130
- IPO Date
- Nov 29, 2023
- Business
- Northern Lights Fund Trust III - Counterpoint Quantitative Equity ETF (CPAI) is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing in a portfolio of U.S. stocks selected through quantitative models and artificial intelligence; the fund employs multiple machine learning algorithms to rank stocks based on over 30 variables spanning value, long-term reversal, momentum, profitability, investor sentiment, and price stability; it dynamically adjusts factor exposures in response to changing market conditions, with a focus on small- and mid-cap companies across all market capitalizations while holding approximately 50 equities diversified across sectors such as energy, consumer non-cyclical, financials, industrials, communications, and technology. CPAI offers investors exposure to high-predicted-return stocks via a tactical model that manages downside risk, with a net expense ratio of 0.75% after waivers; the fund is advised by Counterpoint Funds, LLC, an SEC-registered investment adviser based in San Diego, California, specializing in systematic equity and fixed-income strategies.
Launched on November 28, 2023, and listed initially on NYSE Arca, CPAI transferred its listing to the New York Stock Exchange in late 2024 alongside the Counterpoint High Yield Trend ETF (HYTR), enhancing trading accessibility through most brokerage platforms; this operational shift supports the fund's growth, with assets under management reaching approximately $123 million and shares outstanding at 3.29 million as of November 2025. The Adviser maintains a contractual fee waiver through at least February 1, 2026, ensuring operating expenses do not exceed 0.75% excluding certain costs like brokerage and taxes; no major acquisitions, funding rounds, or strategic alliances have been announced recently, though the fund continues to evolve its AI-driven portfolio rebalancing quarterly.
CPAI targets institutional and retail investors seeking diversified U.S. equity exposure with quantitative enhancement over broad market benchmarks like the S&P 1000 Index; it operates exclusively in U.S. equity markets, with top holdings including Cardinal Health (CAH), Vestis Corp (VSTS), Treehouse Foods (THS), Micron Technology (MU), and Ciena Corp (CIEN) as of late 2025. The fund is distributed by Northern Lights Distributors, LLC, and maintains low correlation to mid-cap blend categories (0.92) and the S&P 500 (0.86), positioning it as a potential diversifier in multi-asset portfolios.